subset of patients, ECV was higher in LV segments with LGE compared to no LGE (p < 0.0001). No significant correlation was identified between global native T1 and ECV and parameters of LV structure and function. Native T1 cut-off of 987 ms provided the highest sensitivity (95 %) and specificity (91 %) to separate HCM patients from controls. Global and segmental native T1 are elevated in HCM patients. LV segments with hypertrophy and/or LGE had higher ECV in a subset of HCM patients. LV native T1 and ECV do not correlate with parameters of LV structure and function. T1 in children and young adults may be used as a non-invasive tool to assess for HCM and related fibrosis.
consented to the T1 MOLLI during their clinically indicated cardiac MRI examination (CMR) between July 2013 and November 2015 were prospectively recruited in the study. The diagnosis of HCM was based on the demonstration of unexplained left ventricular (LV) hypertrophy in non-dilated ventricles in the absence of another cardiac or systemic disease contributing to the extent of hypertrophy. Trans-thoracic echocardiography is the initial modality of investigation in patients with suspected HCM. Practice guidelines for the diagnosis and treatment of HCM recommend exclusion of LV hypertrophy by infiltrative or storages diseases, metabolic disorders, and systemic/syndromic etiologies [13] . These secondary causes of myocardial hypertrophy were excluded clinically prior to labelling the diagnosis of HCM. Genetic mutation responsible for HCM cannot be identified in 30-40 % cases [2] . Genetic analysis was not routinely performed in our cohort to establish the diagnosis of HCM. We recruited controls who were undergoing a clinically indicated CMR examination, consented to the MOLLI sequence, and had normal cardiac function without any known cardiovascular disease, congenital or acquired by history, echocardiography, or MRI.
MR imaging

Clinical CMR protocol
All CMR studies were performed on a 1.5-T MRI scanner (Aera; Siemens AG Healthcare Sector, Erlangen, Germany). General anesthesia was utilized as clinically necessary per our clinical protocol. Balanced short axis steady-state freeprecession (bSSFP) images covering the entire left ventricle (temporal resolution = 37.1 ms TR = 3.1 ms; TE = 1.3 ms; section thickness = 6 mm for young adults and 5 mm for children; field of view = 320mm × 240 mm for young adults and 280-300 mm × 188-225 mm for children) was performed to assess LV systolic function and morphology. Late gadolinium enhancement (LGE) images were acquired approximately 15 min following 0.2 mmol/kg gadopentetate dimeglumine administration (Magnevist; Bayer Healthcare, Wayne, NJ) in short axis, 2-chamber, and 4-chamber planes using both 2-dimensional single-shot and segmented inversion-recovery sequences. Scanning parameters used for single-shot sequence were: TR between 650 and 800 ms, TE 1.8 ms, trigger pulse 2-4 depending on HR,
Introduction
Hypertrophic cardiomyopathy (HCM) is a genetic disease with an incidence of 1:500 in the general population and is associated with ventricular hypertrophy and myocardial fibrosis [1] . Although the phenotypic presentation of HCM is uncommon in children, HCM accounts for 42 % cases of childhood cardiomyopathy [2] . Myocardial interstitial changes can be focal or global with potential for reversibility with treatment in early stages [3, 4] . The final common end point of irreversible fibrosis has been linked to increased risk of cardiac complications [5] . Cardiac MRI (CMR) can be used to non-invasively assess myocardial fibrosis using late gadolinium enhancement (LGE), however quantitative evaluation is limited [6] . T1 mapping is a potential tool for diagnosis of myocardial fibrosis, may be used to monitor therapy, and can serve as a surrogate endpoint in therapy trials [7] .
Altered longitudinal relaxation time due to fibrosis can be noninvasively assessed by quantification of the myocardial native (non-contrast) T1, postcontrast myocardial T1, or calculating extracellular volume (ECV) fraction. Altered native T1 and postcontrast T1 reflects involvement of the myocyte and/or interstitium, while ECV represents the interstitial space [8] . Native T1 has proven to be of clinical relevance in adults with advantages of reduced scan time, cost effectiveness, zero risk of adverse effects from gadolinium-based contrast agents (GBCA), and faster postprocessing relative to calculation of ECV [9, 10] . Postcontrast T1 mapping however cannot be used in patients with contraindications to GBCA injection. There is limited literature on the role of native T1 mapping in children and young adults [11, 12] .
The aim of this study was (a) to determine the reference values of LV native T1 in controls and compare to a group of children and young adults with HCM (b) to investigate the LV ECV in a subset of these HCM patients.
Materials and methods
This study was Health Insurance Portability and Accountability Act (HIPAA)-compliant and approved by our institutional review board (IRB). Informed written consent was obtained for performing the T1 modified Look-Locker (LL) inversion recovery (MOLLI) sequence per the IRB protocol.
Study population
Informed consent was obtained per IRB protocol. All children and young adults <25 years of age with HCM who (1) where S(TI), signal intensity acquired at TI.
Image analysis
LV volumetric, functional analysis and LV mass calculation were derived using QMASS (Medis Medical Imaging Systems, Leiden, the Netherlands) by manual segmentation of the epicardial and endocardial borders by CR, attending radiologist with 15 years of experience in pediatric cardiovascular imaging. Heart rate, LV ejection fraction (LVEF), LV end-diastolic volume index (LVEDV i ) and end-systolic 
MOLLI acquisition
Myocardial T1 maps were obtained in the short-axis plane at the base, mid-chamber, and apex using a singlebreath-hold, ECG-triggered, MOLLI sequence. MOLLI was acquired before and 12 min after contrast injection. The MOLLI sequence acquires single shot SSFP images at different inversion times that are all gated to the same cardiac phase ( Fig. 1) . At the end of each LL scheme, several dummy cardiac cycles are needed for full T1 signal recovery before the net inversion pulse is played out. We optimized our sequence parameters by adjusting the number of recovery heartbeat based on patient's heart rate [14, 15] , which allow for adequate T1 recovery between inversion pulses ( Table 1) . Spatial resolution was also optimized by reducing slice thickness and in-plane pixel size to compensate for partial volume averaging and loss of spatial resolution due to cardiac motion with high heart rates [14] . Other scanning parameters include: number of inversions = 2, MOLLI TI start = 129 ms, MOLLI T1 increment = 80 ms, number of acquisition heartbeats = 5, repetition time (TR) = 2.9 ms, bandwidth = 1050 Hz/pixel, and parallel imaging with a reduction factor of R = 2. Acquisition time will vary depending on heart rate of the patient, typically 11 s for each breath hold. We scanned at three short axis planes at base, mid-chamber, and apex, so overall duration was 3 × 11 s. Pixel based T1 value is calculated by a non-linear curve fitting using the threeparameter signal model [16] , (2) Segmental myocardial hypertrophy was defined as a Z-score of >+2.00 for maximum end-diastolic myocardial wall thickness using EchoIMS (Merge Healthcare, Chicago, IL). LV myocardial segments with normal Z-score were considered non-hypertrophied. Segmental analyses of ECV in a small number of subset of HCM patients was done based on the presence or absence of hypertrophy and/or LGE.
Statistical analyses
Statistical analysis was performed using Microsoft Excel 2011 (Microsoft, Redmond, WA) and JMP ® Pro11.0.0 (SAS Institute, Cary, NC). Quantitative data are presented as mean ± one standard deviation for normative data and median with inter-quartile range (IQR) for nonnormative data. Comparison between two groups was performed using independent samples t test for parametric data and Mann-Whitney test for non-parametric data.
Matched-pair t test was calculated to compare two sets of measurements. One-way analysis of variance (ANOVA) was performed for multiple comparisons of group means. Correlation between continuous variables was evaluated using the Pearson correlation (r) for parametric data and Spearman rank correlation (ρ) for nonparametric data. Receiver operating characteristic curve (ROC) analysis was performed to determine the cut-off LV native T1 to distinguish patients with HCM from controls. All patients with HCM were grouped as positive cases and controls were grouped as negative to determine a threshold for a LV native T1. To reduce the problem of multiple
volume index (LVESV i ), and LV mass index (LV massi) were calculated. Segmental myocardial wall thickness was manually measured in end-diastole on basal, mid-chamber, and apical bSSFP images on PACS (Centricity, General Electric, Milwaukee, WI). LV segments with late gadolinium enhancement were qualitatively evaluated and compared with LV T1. E/A ratio derived from echocardiography within 2 weeks of CMR was used a marker of diastolic dysfunction.
The scale on a color-coded image of the native T1 map can be used to visually determine T1 relaxation time. Manual segmentation of the LV mid-myocardium on short axis T1 maps at the LV basal, mid-chamber and apical slices was performed using a 16-segment AHA model (Fig. 2) . Utmost care was taken to avoid contamination from blood pool or tissue beyond the myocardium. A single radiologist with 2 years of experience in cardiovascular imaging and blinded to results of other clinical data analyzed the MOLLI images on PACS. Segmentation was reviewed for consistency by another observer with 15 years of experience in pediatric cardiovascular imaging and adjustments were made accordingly. Mean T1 values for each segment were used for the data analysis. Segments in the T1 map with poor motion correction were excluded to avoid erroneous values. The mean T1 of the combined 16 LV segments was used to determine global T1.
ECV was calculated using pre- and post-contrast T1 values in those patients who received gadopentetate dimeglumine. CMR scans in patients who did not receive an extracellular contrast agent or in patients that did not have an hematocrit drawn within 7 days of the CMR study were excluded. The regions of interest for the blood pool were placed in the center of the LV to avoid any trabeculations. ECV was calculated using a correction for blood hematocrit. Table 2 . There was no significant difference between the age of HCM patients (mean age 14.1 ± 4.6 years; range 2-21 years) (p = 0.17) and the controls (mean 15.7 ± 1.5 years; range 12-18 years).
LV myocardial native T1
Mean native T1 was higher in females compared to males in HCM group (1057.5 ± 47.8 vs. 1005.6 ± 28.0 ms, p = 0.03). However, no significant gender difference was identified in native T1 (967.2 ± 19.4 ms in females vs. 964.7 ± 16.4 ms in males, p = 0.40). The number of cohort is however very small to draw any conclusions.
An example of a color-coded T1 map in a control (Fig. 3a ) and a patient with hypertrophic cardiomyopathy (HCM) is shown (Fig. 3b ). Twenty-one subjects with HCM had higher global mean LV native T1 (1020.4 ± 41.2 ms) compared to controls (965.6 ± 30.2 ms) (p < 0.001). ROC analysis showed a cut-off global LV native T1 of 987 ms yielding a sensitivity of 95 % and specificity of 91 % for comparisons, the family wise error rate was maintained using Bonferroni correction. Statistical tests conducted were two-tailed. p < 0.05 was considered statistically significant.
Results
Population characteristics
T1 mapping was completed in 45 subjects with 3 patients excluded due to poor motion correction. Our final cohort included 42 subjects (30 males; mean age, 14.9 ± 3.5 years) with native T1 obtained during the clinical CMR examination. There were 21 subjects in the patient group (15 male) (Fig. 4a ). LV native T1 was significantly higher in patients compared to controls on a segmental comparison (AHA 16-segment model) with differences ranging from 3.5 to 6.8 % (Fig. 5) . On segmental analysis of controls, the septum (segments 2, 3, 8, 9, and 14) had a significantly increased native T1 compared to the lateral wall (segments 5, 6, 11, 12, and 16) (973.3 ± 16.7 and 959.2 ± 22.8 ms respectively; p = 0.005). In patients with LV mass i, the values were similar between HCM patients and controls. There was no significant correlation of global LV native T1 with parameters of LV structure and function derived from CMR and echocardiography, namely heart rate, LVEF, LVEDV i , LVESV i , and E/A ratio (ρ = 0.20, 0.05, −0.14, −0.09, and −0.21 respectively). In a subset of HCM patients, ECV did not significantly correlate with heart rate, LVEF, LVEDV i , LVESV i , and E/A ratio (ρ = 0.18, −0.23, 0.01, 0.11, and 0.09 respectively).
Discussion
Our study shows elevated LV native T1 relaxation times in children with HCM compared to controls. Based on our findings, the mean LV native T1 in control children and young adults ranges from 944.0 to 995.0 ms. Mean LV native T1 value in our controls using the MOLLI sequence was similar to the LV native T1 in normal adult subjects (964.6 ± 35.3 ms) as reported by Kellman et al. using a similar T1 mapping sequence [17] .
The higher native T1 in the interventricular septum compared to the lateral LV wall in our study has been described previously [18, 19] . This regional variation is not believed to represent true variability, but can be explained by the introduction of errors from increased sampling error in the lateral wall due to partial volume averaging of voxels at the myocardium-blood and myocardium-lung interface. The increased distance of the receiver coil elements from the lateral wall relative to the interventricular septum, leading to a differential signal gradient between the interventricular septum and the lateral wall could also contribute to this variability. Therefore, some authors suggest only inclusion of the interventricular septum for LV T1 region of interest analysis [20] .
LV native T1 was significantly higher in children with HCM by global and segmental analyses and the non-hypertrophied segments in HCM had higher LV native T1 values compared excluding the septal segments (2, 3, 8, 9, and 14) , mean native T1 of hypertrophied segments (1042.2 ± 44.3 ms) was higher compared to non-hypertrophied segments (993.8 ± 139.3 ms) in HCM patients (p < 0.0001).
LV segments with LGE (63 segments) had higher LV native T1 compared to segments without LGE (269 segments) (1068.5 ± 36.2 vs. 1009.0 ± 48.9 ms, p < 0.001). The cutoff LV native T1 of 1019 ms yielded a sensitivity of 94 % and specificity of 67 % to differentiate segments with and without LGE in patients with HCM and had an area under the ROC of 0.86 (95 % confidence interval, 0.82-0.90) (Fig. 4b) .
Extracellular volume fraction
On segmental analysis in HCM patients, ECV was higher in segments with LV hypertrophy (66 segments) (mean wall thickness, 19.4 mm ± 7.9) compared to non-hypertrophied segments (78 segments) (mean wall thickness, 8.2 mm ± 2.5) (25.3 ± 0.05 vs. 23.7 ± 0.04 %) (p = 0.048, ρ = 0.01). Mean ECV in segments with LGE (54 segments) was significantly elevated compared to segments with no LGE (90 segments) (27.0 ± 0.05 vs. 22.9 ± 0.04 %, p < 0.0001). Comparison of native T1 and ECV between the subgroups pssatient population is illustrated in Table 3 .
Native T1 and clinical variables
Descriptions of quantitative LV structure and function analysis are summarized in Table 4 . With the exception of the conducted prior to using it as a tool for risk stratification. The functional parameters used represent global LV function, which may not decline until later in the disease and can explain the lack of correlation with native T1. Also, we used only one parameter i.e. E/A as a representative of diastolic function. The hematocrit value was not available for all HCM patients limiting comprehensive evaluation of ECV and comparison with LV native T1. We acknowledge the small number of patients with ECV in our study. This study was primarily focused on native T1 and a dedicated study should be performed to determine the role of ECV in children and young adults with HCM. Global and segmental LV native T1 is elevated in patients with HCM relative to controls. LV segments with hypertrophy and/or LGE had higher ECV. LV native T1 and ECV did not correlate with parameters of LV structure and function. Native T1 can be used to quantify myocardial fibrosis in pediatric patients without a risk of neuronal deposition of GBCA. HCM is a progressive disease and T1 mapping can be used to determine disease progression and timely intervention in children and young adults. Further work should be geared to determine whether T1 mapping can be used to guide cardiac risk stratification in children and young adults with HCM. to controls. These findings are compatible with the findings of studies in adults that demonstrate increased T1 relaxation times in both hypertrophied and remote non-hypertrophied myocardium [21, 22] . A study performed by Hinojar et al. showed similar findings with higher native T1 in the septum of adults with gene-positive/phenotype-negative HCM compared to a control population [23] . LV T1 had a very weak correlation with LV wall thickness and LV mass in our population, which suggests the need for a larger study with histopathology correlation to better understand the microscopic process leading to increase in T1 relaxation time of non-hypertrophied and hypertrophied myocardium in children.
In patients with HCM, areas of late gadolinium enhancement (LGE) are representative of replacement fibrosis secondary to microvascular ischemia [24] . Studies have shown that adults with LGE in HCM have higher risk of ventricular arrhythmias and sudden cardiac death [25] . In our study, LV native T1 in HCM was significantly higher in segments with LGE compared to segments with no LGE. Based on our findings, a cut-off LV native T1 of 1019 ms can be used to identify myocardial segments with LGE with high sensitivity. Statistical comparison of global ECV between the two groups was not possible due to the small number of controls. In this study, segments with LGE had a higher ECV with respect to segments without LGE in patients with HCM. Our findings were analogous to what has been described in adults with HCM having LGE [26] .
The significance of T1 mapping to detect subclinical myocardial changes before the onset of systolic and diastolic dysfunction has been described in adults with heart failure [40]. Ellims et al. in their study in adults with 51 HCM patients have described a moderate correlation between post-contrast myocardial T1 and parameters of diastolic function (E/e′) (r = −0.48, p < 0.001) [27] . In our study, factors related to cardiac function including heart rate, LVEF, LVEDV i , LVESV i , and E/A ratio showed no significant association with global LV native T1 in HCM patients or ECV in a subset of HCM patients with available ECV. The differences in results between our study and theirs may be related to our smaller study population and could reflect greater sensitivity of E/e′ ratio for the detection of early changes in cardiac function [27] .
Our study has several limitations. There is an overlap in T1 values between controls and patients that may limit the utility of LV native T1 mapping on an individual patient level. Our results are based on a small cohort and future studies should be conducted in a larger population to provide a guide for clinical applications of T1 mapping in children. We did not correlate LV native T1 or ECV with myocardial histopathology. There is no defined role of endomyocardial biopsy in diagnosis of patients with suspected HCM. However, histological validation of myocardial fibrosis by CMR in children and young adults with HCM should be ideally
